The Latin America, Middle East and Africa Drug Testing Market would witness market growth of 8% CAGR during the forecast period (2021-2027).
Middle Eastern states and the Islamic world are popular for accepting stringent codes of prohibition. Bans on alcohol consumption in Islamic nations and the prohibition of drug testing at workplaces in specific countries of this region would slow down the growth of the regional market in the next few years. The development of this market is due to the increasing drug & alcohol consumption, the imposition of strict laws necessitating drug & alcohol testing, government investment in key markets of this region. These aspects wherein citizens of various countries of the region are prohibited to use drug would hamper the growth & demand for drug testing in the forthcoming years.
The incidence of drug abuse across the Africa continent is exponentially increasing from cannabis abuse to the more pernicious drugs and from a restricted group of drug users to a broader range of people abusing drugs. Thus, these factors are likely to push the demand for drug testing across this continent in the upcoming years.
One of the major benefits of workplace drug testing is that it helps in creating a safer, better, and healthier workplace environment. Companies are getting more aware of the safety of their employees and hence, they want to ensure a drug-free workplace environment. In addition to it, they also understand the fact that employees under the drug influence pose a major risk to other employees. Therefore, many companies are mandating drug testing so as to ensure the overall wellbeing and health of their employees. Moreover, this is particularly relevant for safety-sensitive jobs such as managing harmful chemicals, working with heavy machines, or driving vehicles for the company. If any of the mentioned activities are performed under the influence of the drug, the possibilities of accidents are significantly increased.
The Brazil market dominated the LAMEA Hospitals Drug Testing Market by Country 2020, thereby, achieving a market value of $23.3 million by 2027. The Argentina market would witness a CAGR of 10.9% during (2021 - 2027). Additionally, The UAE market is expected to witness a CAGR of 9.9% during (2021 - 2027).
Based on Drug Type, the market is segmented into Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others. Based on Sample Type, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Product Type, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on End User, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Drug Testing Market is Predict to reach $11.7 Billion by 2027, at a CAGR of 5.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Dragerwerk AG & Co. KGaA, Quidel Corporation, and Omega Laboratories, Inc.
By Drug Type
By Sample Type
By Product Type
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
